Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

Biotechnology
Chemicals
Food processing
Electronics
Healthcare
Pharmaceuticals

Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

Market segmentation
Competitive landscape
Regulatory policies
Latest technology trends
Acquisition evaluations
Vendors’ analysis, etc.

Publications found: 60,074

Sort by:

2017 Singapore Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

January 2017 517 pages

2017 South Korea Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next ... specific product and marketing opportunities emerging during the next five years. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant ...

January 2017 517 pages

2017 Taiwan Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

January 2017 517 pages

2017 Thailand Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

January 2017 517 pages

2017 United Arab Emirates Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... the next five years. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and ... Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison of high ...

January 2017 517 pages

2017 Venezuela Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

January 2017 517 pages

2017 Vietnam Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

January 2017 517 pages

2017 Argentina Hemostasis Diagnostics Market: Reagent, Analyzer and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

US$ 3,105.00

... of current and emerging technologies and their potential market applications. Comprehensive listings of companies developing or marketing new technologies and products by test. Strategic ... expansion opportunities with significant market appeal. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks ...

January 2017 350 pages

2017 Iran Hemostasis Diagnostics Market: Reagent, Analyzer and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

US$ 3,105.00

January 2017 350 pages

2017 Jordan Hemostasis Diagnostics Market: Reagent, Analyzer and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

US$ 3,105.00

January 2017 350 pages

2017 Argentina Virology and Bacteriology Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers

US$ 4,050.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential ...

January 2017 950 pages

2017 Argentina Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Bahrain Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Bangladesh Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Brazil Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Chile Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 China Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Colombia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Croatia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Hong Kong Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year test volume and sales forecasts Feature comparison of major ...

January 2017 1120 pages

2017 India Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Indonesia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Iran Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Iraq Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Israel Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Jordan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Kuwait Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Lebanon Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Malaysia Tumor Marker Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five ... 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing ...

January 2017 1120 pages

2017 Mexico Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Myanmar Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 New Zealand Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with ... portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Opportunities and Strategic Recommendations New product development opportunities with potentially significant ...

January 2017 1120 pages

2017 Oman Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Pakistan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Peru Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Philippines Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Qatar Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Saudi Arabia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Serbia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Singapore Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 South Korea Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Taiwan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Thailand Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 United Arab Emirates Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Venezuela Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2017 Vietnam Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

January 2017 1120 pages

2018 Argentina Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review

US$ 4,250.00

... for over 30 NAT assays Product/Technology Review Comparison of leading molecular diagnostic analyzers.- Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...

January 2017 1120 pages

2018 Bahrain Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review

US$ 4,250.00

January 2017 1120 pages

2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

US$ 22,050.00

... new report from VPGMarketResearch.com provides granular analysis of the Middle East diagnostic testing market, including Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...

January 2017 410 pages

2017 Latin America Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

US$ 15,750.00

... new report from VPGMarketResearch.com provides granular analysis of the Latin America diagnostic testing market, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...

January 2017 260 pages

Filters

Clear all

Publishers

Venture Planning Group

60,074

Price

—

Date

—

Pages

—

Offers